Clinical trial registry record

Genetic Study of Age Related Hearing Loss

A registered EARLY_PHASE1 study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Completed.
Evidence
Registered early phase 1 study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated November 22, 2012.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT01732289
Last registry update
November 22, 2012
Status
Completed
Phase
EARLY Phase 1
Sponsor
National Taiwan University Hospital
Enrollment
1000
Countries
Taiwan
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered EARLY_PHASE1 study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
EARLY Phase 1
Study design
NON RANDOMIZED · PARALLEL · DIAGNOSTIC · SINGLE
Evidence population
Human clinical study registration
Participants
1000
Population
ALL · 45 Months
Duration
2008-08-01 to 2009-07-01
Intervention
genes
Comparator
Not reported
Outcomes measured
which gene or Single nucleotide polymorphism is related to age related hearing loss — 2008-2009; Which environmental factor(s) or systemic diseases are related to age related hearing loss — 2008-2009
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · EARLY Phase 1A trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Hearing ageing · 100%Abstract contains controlled term: age-related hearing loss, presbycusis. Source terminology contains: age-related hearing loss, presbycusis. Abstract supplies longevity context: age-related, elderly. Study type is explicitly identified as INTERVENTIONAL.

Automated source check 100% · update recency 35%. These figures help sort records; they are not medical ratings.

hearing aging
Open primary sourceExport JSON